Which of the following patients is most likely to benefit from glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy? A. A patient with prediabetes and no cardiovascular (CV) risk factors B. A patient with type 1 diabetes (T1D) and proliferative diabetic retinopathy C. A patient with type 2 diabetes (T2D) and a history of atherosclerotic cardiovascular disease (ASCVD) D. A patient with T2D and severe gastroparesis
[Expert Solution]: Which of the following patients is most…
Need help with your Endocrine & Metabolic Disorders case study or NCLEX preparation? Connect with a verified Nursing expert now.
